Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Orange Book Blog: At the Intersection of Patent Law and FDA Law

Intellectual Property Law

: Orange Book Blog: At the Intersection of Patent Law and FDA Law

Sanofi Prevails Over Apotex in Plavix Appeal

By Aaron Barkoff

Sanofi-Synthelabo et al. v. Apotex, No. 2007-1438 (Fed. Cir. 2008)

The Federal Circuit today affirmed the decision of the U.S. District Court for the Southern District of New York, following a 2007 bench trial, that Sanofi's U.S. Patent No. 4,847,265 is not invalid for anticipation or obviousness.  The '265 patent covers clopidogrel bisulfate, the active ingredient in Plavix.

For today's opinion, click here.

More later...

Full post as published by Orange Book Blog: At the Intersection of Patent Law and FDA Law on December 12, 2008 (boomark / email).